Abstract
Brochure answering frequently asked questions about the resumption of vaccination with the Oxford / AstraZeneca vaccine after being endorsed by the European Medicines Agency that a cause-and-effect relationship between the administration of the vaccine and the risk of blood clots in those who receive it.
Keywords
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Vaccination; Oxford/AstraZeneca; Frequently asked questions
Bibliographic citation
Represa de la vacunació amb Oxford/AstraZeneca: preguntes freqüents per a la ciutadania [fullet]. Barcelona: Servei Català de la Salut; 2021.
Audience
Ciutadania
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/5797This item appears in following collections
The following license files are associated with this item: